|
ADH5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62792002100787E-12 |
| Normal-vs-Stage2 |
6.15160034023177E-10 |
| Normal-vs-Stage3 |
3.91679999989236E-07 |
| Normal-vs-Stage4 |
9.5688999945942E-08 |
| Stage1-vs-Stage2 |
8.591600E-01 |
| Stage1-vs-Stage3 |
3.367600E-01 |
| Stage1-vs-Stage4 |
6.798000E-01 |
| Stage2-vs-Stage3 |
5.135000E-01 |
| Stage2-vs-Stage4 |
5.411000E-01 |
| Stage3-vs-Stage4 |
3.911600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.55526719175714E-12 |
| Normal-vs-Asian |
8.603700E-02 |
| Caucasian-vs-AfricanAmerican |
7.761200E-01 |
| Caucasian-vs-Asian |
9.563600E-01 |
| AfricanAmerican-vs-Asian |
9.972000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
1.97863947448695E-12 |
| Male-vs-Female |
8.147600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.75760020058181E-10 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
8.49320613838245E-14 |
| Normal-vs-Extreme_Obese |
7.99250000000917E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.280400E-01 |
| Normal_Weight-vs-Obese |
6.501600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.651600E-01 |
| Extreme_Weight-vs-Obese |
3.894200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.545150E-01 |
| Obese-vs-Extreme_Obese |
3.316800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.3371999587124E-09 |
| Normal-vs-Age(41-60Yrs) |
6.53921361504217E-14 |
| Normal-vs-Age(61-80Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(81-100Yrs) |
1.373400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.097200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.260400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.843600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.359400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.414950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.970300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
1.17999999993401E-07 |
| Normal-VS-KIRP CIMP |
2.37669994795908E-10 |
| Normal-VS-Unclassified PRCC |
9.88054082995404E-12 |
| Type1 PRCC-VS-Type2 PRCC |
6.381500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.182400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.374800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.004690E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.724000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.103840E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.07209948988441E-10 |
| Normal-vs-N1 |
1.54709999999891E-06 |
| Normal-vs-N2 |
9.06519999954725E-07 |
| N0-vs-N1 |
8.567800E-01 |
| N0-vs-N2 |
2.629500E-04 |
| N1-vs-N2 |
6.000600E-03 |
|
|
